Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorCOSTE, Florence
dc.contributor.authorGUIBERT, Christelle
dc.contributor.authorMAGAT, Julie
dc.contributor.authorABELL, Emma
dc.contributor.authorVAILLANT, Fanny
dc.contributor.authorDUBOIS, Mathilde
hal.structure.identifierUnité de Recherche Oenologie [Villenave d'Ornon] [OENO]
dc.contributor.authorCOURTOIS, Arnaud
IDREF: 092021301
dc.contributor.authorDIOLEZ, Philippe
dc.contributor.authorQUESSON, Bruno
dc.contributor.authorMARTHAN, Roger
dc.contributor.authorSAVINEAU, Jean-Pierre
dc.contributor.authorMULLER, Bernard
dc.contributor.authorFREUND-MICHEL, Véronique
dc.date.accessioned2021-05-31T13:39:04Z
dc.date.available2021-05-31T13:39:04Z
dc.date.issued2017-03-14
dc.identifier.issn1465-993Xen_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/78762
dc.descriptionArticle cliniqueen_US
dc.description.abstractEnPulmonary arterial hypertension (PAH) is a severe form of pulmonary hypertension that combines multiple alterations of pulmonary arteries, including, in particular, thrombotic and plexiform lesions. Multiple-pathological-insult animal models, developed to more closely mimic this human severe PAH form, often require complex and/or long experimental procedures while not displaying the entire panel of characteristic lesions observed in the human disease. In this study, we further characterized a rat model of severe PAH generated by combining a single injection of monocrotaline with 4 weeks exposure to chronic hypoxia. This model displays increased pulmonary arterial pressure, right heart altered function and remodeling, pulmonary arterial inflammation, hyperresponsiveness and remodeling. In particular, severe pulmonary arteriopathy was observed, with thrombotic, neointimal and plexiform-like lesions similar to those observed in human severe PAH. This model, based on the combination of two conventional procedures, may therefore be valuable to further understand the pathophysiology of severe PAH and identify new potential therapeutic targets in this disease.
dc.language.isoENen_US
dc.subject.enAnimals
dc.subject.enArterial Pressure
dc.subject.enChronic Disease
dc.subject.enDisease Models
dc.subject.enAnimal
dc.subject.enHumans
dc.subject.enHypertension
dc.subject.enPulmonary
dc.subject.enHypoxia
dc.subject.enMale
dc.subject.enMonocrotaline
dc.subject.enPulmonary Artery
dc.subject.enRats
dc.subject.enRats
dc.subject.enWistar
dc.subject.enSeverity of Illness Index
dc.subject.enVascular Resistance
dc.title.enChronic hypoxia aggravates monocrotaline-induced pulmonary arterial hypertension: a rodent relevant model to the human severe form of the disease.
dc.title.alternativeRespir Resen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1186/s12931-017-0533-xen_US
dc.subject.halSciences du Vivant [q-bio]/Biologie végétaleen_US
dc.identifier.pubmed28288643en_US
bordeaux.journalRespiratory Researchen_US
bordeaux.page47en_US
bordeaux.volume18en_US
bordeaux.hal.laboratoriesUnité de Recherche Oenologie - EA 4577en_US
bordeaux.issue1en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionBordeaux INPen_US
bordeaux.institutionINRAEen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.import.sourcepubmed
hal.exportfalse
workflow.import.sourcepubmed
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Respiratory%20Research&rft.date=2017-03-14&rft.volume=18&rft.issue=1&rft.spage=47&rft.epage=47&rft.eissn=1465-993X&rft.issn=1465-993X&rft.au=COSTE,%20Florence&GUIBERT,%20Christelle&MAGAT,%20Julie&ABELL,%20Emma&VAILLANT,%20Fanny&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée